Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc.
| Novartis Pharmaceuticals Corporation and Novartis AG |
| Par Pharmaceutical Inc. |
| 1:2014cv01289 |
| October 10, 2014 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Richard G. Andrews |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
198
MEMORANDUM ORDER: Plaintiff's Motion for Estoppel (C.A. No. 14-1289, D.I. 193; C.A. No. 14-1494, D.I. 120 ; C.A. No. 15-78, D.I. 120) is GRANTED as to claims 1-3 and 8-10 of the '772 patent, and the parties are to submit a joint status report concerning the covenant not to sue and a joint proposed form of order and judgment within two weeks of this order. Signed by Judge Richard G. Andrews on 4/11/2019. Associated Cases: 1:14-cv-01289-RGA, 1:14-cv-01494-RGA, 1:15-cv-00078-RGA(nms)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
